BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32751711)

  • 1. MicroRNA-Dependent Targeting of RSU1 and the IPP Adhesion Complex Regulates the PTEN/PI3K/AKT Signaling Pathway in Breast Cancer Cell Lines.
    Kim YC; Cutler ML
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rsu1 contributes to cell adhesion and spreading in MCF10A cells via effects on P38 map kinase signaling.
    Kim YC; Gonzalez-Nieves R; Cutler ML
    Cell Adh Migr; 2015; 9(3):227-32. PubMed ID: 25482629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rsu1 contributes to regulation of cell adhesion and spreading by PINCH1-dependent and - independent mechanisms.
    Gonzalez-Nieves R; Desantis AI; Cutler ML
    J Cell Commun Signal; 2013 Dec; 7(4):279-93. PubMed ID: 23765260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex structures of Rsu1 and PINCH1 reveal a regulatory mechanism of the ILK/PINCH/Parvin complex for F-actin dynamics.
    Yang H; Lin L; Sun K; Zhang T; Chen W; Li L; Xie Y; Wu C; Wei Z; Yu C
    Elife; 2021 Feb; 10():. PubMed ID: 33587032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rsu1-dependent control of PTEN expression is regulated via ATF2 and cJun.
    Kim YC; Gonzalez-Nieves R; Cutler ML
    J Cell Commun Signal; 2019 Sep; 13(3):331-341. PubMed ID: 30680530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells.
    Dougherty GW; Jose C; Gimona M; Cutler ML
    Eur J Cell Biol; 2008 Sep; 87(8-9):721-34. PubMed ID: 18436335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
    Zhang XY; Mao L
    Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASP1 promotes glioma cell proliferation and migration and is negatively regulated by miR-377-3p.
    Liu Y; Gao Y; Li D; He L; Iw L; Hao B; Chen X; Cao Y
    Biomed Pharmacother; 2018 Dec; 108():845-851. PubMed ID: 30372896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling.
    Zhang LF; Zhang JG; Zhou H; Dai TT; Guo FB; Xu SY; Chen Y
    Kaohsiung J Med Sci; 2020 Apr; 36(4):250-256. PubMed ID: 31688991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
    Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
    Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
    Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
    Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
    FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-202-5p/
    Liu T; Guo J; Zhang X
    Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
    Chen HH; Huang WT; Yang LW; Lin CW
    Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.